We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
The Evolving Treatment Paradigm for RRMM: The Role of Bispecific Antibodies
Sagar Lonial, MD, FACP
Caitlin Costello, MD
Integrating Bispecific Antibodies Into Clinical Practice
Step-Up Dosing of Bispecific Antibodies: The Need for Hospitalization
Optimizing ICH Care By Leveraging AC Reversal, AI & Care Bundling
W. Brian Gibler, MD, FACEP, FACC, FAHA
Greg Albers, MD
Rhonda Cadena, MD, FNCS, FCCM
Stuart Connolly, MD, FRCPC
Natalie Kreitzer, MD, MS
Adrian R. Parry-Jones, FRCP, PhD
Emerging Data in the Management of Intracranial Hemorrhage in the Anticoagulated Patient
The Frontier of Stroke Diagnosis (RapidAI): How Can Artificial Intelligence Improve Acute Care for Ischemic and Hemorrhagic Stroke?
Implementation of the 2022 AHA/ASA Guideline for the Management of Patients with Spontaneous Intracerebral Hemorrhage—Are You Doing Enough?
Providing Optimal Care for the Anticoagulated Patient with Intracranial Hemorrhage in the Acute Care Setting: Does the Patient Need Reversal, Repletion, or Surgery?
ABC-ICH: Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?
Selecting an AUD Treatment: Naltrexone
Ethan A. Cowan, MD
Edwin A. Salsitz, MD, DFASAM
Standardized Screening Tools for AUD
Annie Levesque, MD, MSc
Epidemiology of AUD and Patient Stratification
Case-Based AUD Challenge
Improved Strategies for Treating Alcohol Use Disorder (AUD)
Selecting an AUD Treatment: Off-Label Agents
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education